BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36119531)

  • 21. Irreversible Electroporation For Hepatocellular Carcinoma: Longer-Term Outcomes At A Single Centre.
    Freeman E; Cheung W; Kavnoudias H; Majeed A; Kemp W; Roberts SK
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):247-253. PubMed ID: 33051707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Irreversible electroporation in the treatment of locally advanced pancreatic cancer].
    Záruba P; Hoskovec D; Lacman J; Hořejš J; Krška Z; Ryska M
    Rozhl Chir; 2015 Dec; 94(12):504-9. PubMed ID: 26767900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction.
    Arena CB; Sano MB; Rossmeisl JH; Caldwell JL; Garcia PA; Rylander MN; Davalos RV
    Biomed Eng Online; 2011 Nov; 10():102. PubMed ID: 22104372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irreversible electroporation: a new ablation modality--clinical implications.
    Rubinsky B; Onik G; Mikus P
    Technol Cancer Res Treat; 2007 Feb; 6(1):37-48. PubMed ID: 17241099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Irreversible electroporation: a new form of image-guided tumour ablation].
    Scheffer H; Nielsen K; van Tilborg A; Vieveen JM; van den Tol MP; Meijerink MR
    Ned Tijdschr Geneeskd; 2014; 158():A7176. PubMed ID: 24518847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irreversible Electroporation Enhanced by Radiofrequency Ablation: An In Vitro and Computational Study in a 3D Liver Tumor Model.
    Fang Z; Mao H; Moser MAJ; Zhang W; Qian Z; Zhang B
    Ann Biomed Eng; 2021 Sep; 49(9):2126-2138. PubMed ID: 33594637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irreversible Electroporation for Liver Metastases from Colorectal Cancer: A Systematic Review.
    Spiers HVM; Lancellotti F; de Liguori Carino N; Pandanaboyana S; Frampton AE; Jegatheeswaran S; Nadarajah V; Siriwardena AK
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irreversible electroporation ablation: is all the damage nonthermal?
    Faroja M; Ahmed M; Appelbaum L; Ben-David E; Moussa M; Sosna J; Nissenbaum I; Goldberg SN
    Radiology; 2013 Feb; 266(2):462-70. PubMed ID: 23169795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
    Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
    Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irreversible electroporation of the liver and liver hilum in swine.
    Charpentier KP; Wolf F; Noble L; Winn B; Resnick M; Dupuy DE
    HPB (Oxford); 2011 Mar; 13(3):168-73. PubMed ID: 21309933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transchondral access for irreversible electroporation of hepatocellular carcinoma.
    Elboraey M; Devcic Z; Lewis AR; Ritchie CA; Frey GT; Paz-Fumagalli R; McKinney JM; Toskich BB
    Radiol Case Rep; 2020 May; 15(5):531-533. PubMed ID: 32153694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent Colorectal Liver Metastases in the Liver Remnant After Major Liver Surgery-IRE as a Salvage Local Treatment When Resection and Thermal Ablation are Unsuitable.
    Hitpass L; Distelmaier M; Neumann UP; Schöning W; Isfort P; Keil S; Kuhl CK; Bruners P; Barabasch A
    Cardiovasc Intervent Radiol; 2022 Feb; 45(2):182-189. PubMed ID: 34757483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft.
    Niessen C; Jung EM; Wohlgemuth WA; Trabold B; Haimerl M; Schreyer A; Stroszczynski C; Wiggermann P
    Korean J Radiol; 2013; 14(5):797-800. PubMed ID: 24043975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy.
    Davalos RV; Bhonsle S; Neal RE
    Prostate; 2015 Jul; 75(10):1114-8. PubMed ID: 25809014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Liver regeneration after radiofrequency ablation versus irreversible electroporation].
    Li S; Zeng Q; Zhong R; Mao S; Shen L; Wu P
    Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(1):66-8. PubMed ID: 25876814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
    Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irreversible electroporation: implications for prostate ablation.
    Onik G; Mikus P; Rubinsky B
    Technol Cancer Res Treat; 2007 Aug; 6(4):295-300. PubMed ID: 17668936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue heterogeneity in structure and conductivity contribute to cell survival during irreversible electroporation ablation by "electric field sinks".
    Golberg A; Bruinsma BG; Uygun BE; Yarmush ML
    Sci Rep; 2015 Feb; 5():8485. PubMed ID: 25684630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irreversible Electroporation For Liver Tumors: A Review Of Literature.
    Tameez Ud Din A; Tameez-Ud-Din A; Chaudhary FMD; Chaudhary NA; Siddiqui KH
    Cureus; 2019 Jun; 11(6):e4994. PubMed ID: 31497425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
    Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
    PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.